ZuikM, MandelMA. Methotrexate-salicylate interaction: a clinical and experimental study.Surg Forum1975; 26: 567–9.
2.
DubinHV, HarrellER. Liver disease associated with methotrexate treatment of psoriatic patients.Arch Dermatol1970; 102: 498–503.
3.
AdamsJD, HunterGA. Drug interaction in psoriasis.Aust J Dermatol1976; 17: 39–40.
4.
EllisonNM, ServiRJ. Acute renal failure and death following sequential intermediate-dose methotrexate and 5-FU: a possible adverse effect due to concomitant indomethacin administration.Cancer Treat Rep1985; 69: 342–3.
5.
MaichieAG. Acute renal failure due to concomitant action of methotrexate and indomethacin (letter).Lancet1986; 1: 1390.
6.
SinghRR, MalaviyaAN, PandeyJN, GuleriaJS. Fatal interaction between methotrexate and naproxen (letter).Lancet1986; 1: 1390.
7.
ThyssA, MilanoG, KubarJ, NamerM, SchneiderM. Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen (letter).Lancet1986; 1: 256–8.
8.
DalyH, BoyleJ, RobertsC, ScottG. Interaction between methotrexate and non-steroidal anti-inflammatory drugs.Lancet1986; 1: 557.
